BNGO · Bionano Genomics, Inc. · Exempt Offerings
$1.00
-0.04 (-3.85%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Nov 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, we determined that there is substantial doubt about our ability to continue as a going concern within 12 months after the date that the financial statements included in this Quarterly Report are issued.”View the 10-Q filed Nov 10, 2026
Market Cap
$13.99M
Shares
13.99M
Volume · Nov 13
557.57K
Avg daily vol (3M)
965.62K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2024-07-10 | New | Biotechnology | $20,000,001 | $20,000,001 | 06b |
| 2024-06-05 | New | Biotechnology | $20,000,000 | $20,000,000 | 06b |
| 2023-10-27 | New | Other Health Care | $35,000,000 | $35,000,000 | 06b |
| 2021-10-25 | New | Other Health Care | $41,850,386 | $41,850,386 | 06b |
Showing 1–4 of 4 filings
Key facts
CIK
1411690
CUSIP
09075F404
13F (30d)
44 filings
26 filers
Visit website
Investor relations